Open, single-blind, double-blind: which peer review process do you prefer?

被引：23

作者：

Moylan, Elizabeth C. ^{[1
]}

Harold, Simon

O'Neill, Ciaran ^{[1
]}

Kowalczuk, Maria K. ^{[1
]}

机构：

[1] BioMed Cent Ltd, London WC1X 8HL, England

来源：

BMC PHARMACOLOGY & TOXICOLOGY | 2014年 / 15卷

关键词：

JOURNALS;

D O I：

10.1186/2050-6511-15-55

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

BMC Pharmacology and Toxicology was created from the merger of two journals within the BMC series published by BioMed Central: BMC Pharmacology and BMC Clinical Pharmacology. BMC Pharmacology operated anonymous peer review whereas BMC Clinical Pharmacology operated a fully open peer review policy where the identity of the reviewers was known to the editors, authors and readers. The merged journal also adopted a fully open peer review policy. Two years on we discuss the views and experiences of our Editorial Board Members towards open peer review on this biomedical journal.

引用

页数：5

共 27 条

[1]

Amsen E, WHAT IS OPEN PEER RE

[2] Working double-blind [J].